Evidence map›Paper›PMID 37604229›Full record

ArticleJournal of the American Academy of Dermatology2024

Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.

Maria C Schneeweiss, Richard Wyss, Sebastian Schneeweiss, Priyanka Anand, Yinzhu Jin, Elyse Dicesare, Robert J Glynn, Joseph F Merola

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.American journal of clinical dermatology · 2024
    Review
  5. Adverse effects of biologics used to treat asthma.Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria C SchneeweissDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: mschneeweiss@bwh.harvard.edu.
Richard WyssDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Sebastian SchneeweissDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Priyanka AnandDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Yinzhu JinDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Elyse DicesareDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Robert J GlynnDivision of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Joseph F MerolaDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Brigham and Women's Hospital · USHarvard University · US

Funding

New approaches to safety monitoring of novel systemic treatments for atopic dermatitis in clinical practice and underrepresented populationsR01AR080194 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Sebastian G. Schneeweiss · 2022 to 2026
$3.3M
NIAMS NIH HHS R01 AR080194
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dermatitis, AtopicAntibodies, Monoclonal, HumanizedArthralgiaCohort StudiesDouble-Blind MethodHumansSeverity of Illness IndexTreatment OutcomeAntibodies, Monoclonal, Humanizeddupilumabarthralgiaarthritisatopic dermatitisdupilumabepidemiologyimmunomodulating drugssafetysystemic medications

Identifiers

PMID37604229
PMCPMC11590678
OpenAlexW4385999293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.